Exact Mass: 634.3716784
Exact Mass Matches: 634.3716784
Found 483 metabolites which its exact mass value is equals to given mass value 634.3716784,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Soyasapogenol B 3-O-b-D-glucuronide
Soyasapogenol B 3-O-b-D-glucuronide is found in tea. Soyasapogenol B 3-O-b-D-glucuronide is a constituent of the seeds of Trifolium incarnatum (crimson clover). Constituent of the seeds of Trifolium incarnatum (crimson clover). Soyasapogenol B 3-O-b-D-glucuronide is found in tea.
Momordicin II
Momordicin II is found in bitter gourd. Momordicin II is a constituent of Momordica charantia (bitter melon) Constituent of Momordica charantia (bitter melon). Momordicin II is found in bitter gourd and fruits.
Momordicoside L
Momordicoside L is found in bitter gourd. Momordicoside L is a constituent of Momordica charantia (bitter melon) Constituent of Momordica charantia (bitter melon). Momordicoside L is found in bitter gourd and fruits.
(3b,20R,22R)-3,20,27-Trihydroxy-1-oxowitha-5,24-dienolide 3-glucoside
(3b,20R,22R)-3,20,27-Trihydroxy-1-oxowitha-5,24-dienolide 3-glucoside is found in fruits. (3b,20R,22R)-3,20,27-Trihydroxy-1-oxowitha-5,24-dienolide 3-glucoside is a constituent of Physalis peruviana (Cape gooseberry).
Lucyoside Q
Lucyoside Q is found in fruits. Lucyoside Q is a constituent of Luffa cylindrica (smooth luffa) Constituent of Luffa cylindrica (smooth luffa). Lucyoside Q is found in fruits.
28-Glucosylpomolate
28-Glucosylpomolate is found in herbs and spices. 28-Glucosylpomolate is a constituent of Sanguisorba officinalis (burnet bloodwort). Constituent of Sanguisorba officinalis (burnet bloodwort). 28-Glucosylpomolate is found in tea and herbs and spices.
Maslinic acid 3-O-b-D-glucoside
Maslinic acid 3-O-b-D-glucoside is found in fruits. Maslinic acid 3-O-b-D-glucoside is a constituent of Luffa cylindrica (smooth luffa). Constituent of Luffa cylindrica (smooth luffa). Lucyoside O is found in fruits.
2alpha-Hydroxypyracrenic acid
2alpha-Hydroxypyracrenic acid is found in fruits. 2alpha-Hydroxypyracrenic acid is a constituent of Zizyphus jujuba (Chinese date) Constituent of Zizyphus jujuba (Chinese date). 2alpha-Hydroxypyracrenic acid is found in fruits.
3-trans-p-Coumaroylrotundic acid
3-trans-p-Coumaroylrotundic acid is found in fruits. 3-trans-p-Coumaroylrotundic acid is a constituent of Eriobotrya japonica (loquat). Constituent of Eriobotrya japonica (loquat). 3-trans-p-Coumaroylrotundic acid is found in loquat and fruits.
Digitoxigenin bisdigitoxide
2-(4-Hydroxy-1,3-thiazol-3-ium-3-yl)ethyl [2-(octadecylcarbamoyloxymethyl)oxolan-2-yl]methyl phosphate
PA(10:0/5-iso PGF2VI)
PA(10:0/5-iso PGF2VI) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/5-iso PGF2VI), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(5-iso PGF2VI/10:0)
PA(5-iso PGF2VI/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(5-iso PGF2VI/10:0), in particular, consists of one chain of one 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(8:0/PGF2alpha)
PA(8:0/PGF2alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGF2alpha), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin F2alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(PGF2alpha/8:0)
PA(PGF2alpha/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGF2alpha/8:0), in particular, consists of one chain of one Prostaglandin F2alpha at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(8:0/PGE1)
PA(8:0/PGE1) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGE1), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin E1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(PGE1/8:0)
PA(PGE1/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGE1/8:0), in particular, consists of one chain of one Prostaglandin E1 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(8:0/PGD1)
PA(8:0/PGD1) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGD1), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin D1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(PGD1/8:0)
PA(PGD1/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGD1/8:0), in particular, consists of one chain of one Prostaglandin D1 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
28-Glc-hederagenin
Hederagenin 28-O-beta-D-glucopyranoside is a triterpenoid saponin that is the carboxylic ester obtained by the formal condensation of the carboxy group of hederagenin with beta-D-glucopyranose. It has been isolated from Juglans sinensis. It has a role as a plant metabolite and an anti-inflammatory agent. It is a triterpenoid saponin, a pentacyclic triterpenoid, a monosaccharide derivative, a beta-D-glucoside and a carboxylic ester. It is functionally related to a hederagenin. It derives from a hydride of an oleanane. hederagenin 28-O-beta-D-glucopyranosyl ester is a natural product found in Kalopanax septemlobus, Acer pictum, and other organisms with data available. A triterpenoid saponin that is the carboxylic ester obtained by the formal condensation of the carboxy group of hederagenin with beta-D-glucopyranose. It has been isolated from Juglans sinensis. Hederagenin 28-O-beta-D-glucopyranosyl ester, a triterpenoid saponin isolated from Ilex cornuta, exhibits protective effects against H2O2-induced myocardial cell injury[1].
Gleditsoside B
Echinocystic acid 3-glucoside is a triterpenoid saponin. Ecliptasaponin A is a natural product found in Eclipta alba and Eclipta prostrata with data available. Ecliptasaponin A , a pentacyclic triterpenoid saponin, is one of major compounds separated from Eclipta prostrate[1]. Eclipta prostrate is considered as a nourishing herbal medicine with pleiotropic effects, including anti-inflammatory, hepatoprotective, antioxidant, and immunomodulatory[2]. Ecliptasaponin A , a pentacyclic triterpenoid saponin, is one of major compounds separated from Eclipta prostrate[1]. Eclipta prostrate is considered as a nourishing herbal medicine with pleiotropic effects, including anti-inflammatory, hepatoprotective, antioxidant, and immunomodulatory[2].
Ecliptasaponin D
Ecliptasaponin D is a triterpenoid glucoside isolated from Eclipta alba (L.) Hassk which is the aerial part of Eclipta prostrate. Eclipta prostrate is considered as a nourishing herbal medicine with pleiotropic effects, including anti-inflammatory, hepatoprotective, antioxidant and immunomodulatory[1,2]. Ecliptasaponin D is a triterpenoid glucoside isolated from Eclipta alba (L.) Hassk which is the aerial part of Eclipta prostrate. Eclipta prostrate is considered as a nourishing herbal medicine with pleiotropic effects, including anti-inflammatory, hepatoprotective, antioxidant and immunomodulatory[1,2].
Ecliptasaponin
Echinocystic acid 3-glucoside is a triterpenoid saponin. Ecliptasaponin A is a natural product found in Eclipta alba and Eclipta prostrata with data available. Ecliptasaponin A , a pentacyclic triterpenoid saponin, is one of major compounds separated from Eclipta prostrate[1]. Eclipta prostrate is considered as a nourishing herbal medicine with pleiotropic effects, including anti-inflammatory, hepatoprotective, antioxidant, and immunomodulatory[2]. Ecliptasaponin A , a pentacyclic triterpenoid saponin, is one of major compounds separated from Eclipta prostrate[1]. Eclipta prostrate is considered as a nourishing herbal medicine with pleiotropic effects, including anti-inflammatory, hepatoprotective, antioxidant, and immunomodulatory[2].
Myriceric acid B
trans-3beta-Caffeoyloxy-2alpha-hydroxyurs-12-en-28-oic acid
3,6,9,12,15,18,21,24,27,30,33,36,39-Tridecaoxahentetracontane-1,41-diol
(3S,4S,6aR,6bS,8R,8aR,12aS,14bR)-8-hydroxy-4,6a,6b,11,11,14b-hexamethyl-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylic acid
jaspamide O
A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it has been shown to exhibit cytotoxic and microfilament disruption activity.
(23R)-7beta,23-dihydroxycucurbita-5,24-dien-19-al 3-O-beta-D-allopyranoside|charantoside B
3-(3-hydroxy-5,18-seco-ibogamin-12-yl)-vobasan-17-oic acid methyl ester|Capuvosin
C40H50N4O3 (634.3882709999999)
23-cis-p-coumaroyloxy-2alpha,3alpha-dihydroxyolean-12-en-28-oic acid
3beta-[beta-glucopyranosyloxyuronic acid]-16-hydroxy-5alpha,14beta-poriferast-16-ene-15,23-dione|pandaroside B
17-hydroxy-24-O-beta-D-glucopyranosyl-hopan-28,22-olide
ajugatakasin B
A diterpene lactone isolated from the whole plants of Ajuga ciliata that is ajugatakasin A in which both of the 2-methylbutenoate ester goups have been hydrogenated to the corresponding 2-methylbutanoates.
3-O-beta-D-glucopyranosyl 3alpha,11alpha-dihydroxylup-20(29)-en-28-oic acid
3beta,30-dihydroxy-12-ursen-28-oic acid 28-O-beta-D-glucopyranosyl ester
3beta-cis-p-coumaroyloxy-2alpha,3beta,13beta-trihydroxy-urs-11-en-28-oic acid
23-hydroxyimberbic acid 23-O-alpha-L-rhamnopyranoside
3-O-(beta-D-glucopyranosyl)-23-hydroxyursolic acid|3-O-beta-D-glucopyranosyl-23-hydroxyursolic acid|ilexoside XXV
3-O-beta-D-allopyranosyl-7beta,25-dihydroxycucurbita-5,23(E)-dien-19-al|7beta,25-dihydroxycucurbita-5,23(E)-dien-19-al 3-O-beta-D-allopyranosyl
3beta,23-dihydroxy-lup-20(29)-en-28-oic acid 3beta-caffeate
3beta,16beta,23-trihydroxy-13,28-epoxyurs-11-ene-3-O-beta-D-glucopyranoside
25-O-methoxycimigenol 3-O-alpha-L-arabinopyranoside|25-O-methylcimigenol-3-O-alpha-L-arabinopyranoside|cimiracemoside B
hederagenin 23-O-beta-D-glucopyranoside (CP2a)|Prosapogenin CP2a
(3R,5beta,16S,17S,20R,22S,23S,24S,25S)-16,23:16,27:22,25-triepoxy-17-hydroxystigmast-7-en-3-yl beta-D-glucopyranoside|ajugasalicioside A
didigitoxosyldigitoxigenin|digitoxigen O-[2,6-dideoxy-beta-D-ribo-hexopyranosyl]-(1->4)-(2,6-dideoxy-beta-D-ribo-hexopyranoside)|digitoxigenin 2,6-dideoxy-4-O-[2,6-dideoxy-beta-D-ribo-hexopyranosyl]-beta-D-ribo-hexopyranoside|digitoxigenin 3-O-beta-D-digitoxosyl-(1<*>4)-beta-D-digitoxoside|digitoxigenin bis-digitoxose|digitoxigenin bisdigitoxoside|digitoxigenin-3-O-beta-D-digitoxosyl-(1->4)-beta-D-digitoxoside
2-O-caffeoyl maslinic acid
A pentacyclic triterpenoid that is the 2-O-caffeoyl derivative of maslinic acid. It is isolated from the branch barks of Hippophae rhamnoides and acts as a radical scavenger.
3beta-O-beta-D-glucopyranosyloxy-16beta,26,29-trihydroxy-5alpha-stigmasta-7,9(11),24(28)Z-trien-6-one
5beta,19-epoxycucurbita-6,24-dien-3beta,22xi,23xi-triol 23-O-beta-D-allopyranoside|karaviloside VIII
25-O-acetyl-3-O-[2-O-acetyl-beta-D-arabinopyranosyl]cholest-5-ene-3beta,19,25-triol|junceelloside G
(3beta,7beta,23S)-3,7,23-trihydroxycucurbita-5,24-dien-19-al 7-beta-D-glucopyranoside|(3beta,7beta,9beta,10alpha,23S)-7-(beta-D-glucopyranosyloxy)-3,23-dihydroxy-19-norlanosta-5,24-diene-9-carboxaldehyde
3beta,29-dihydroxy-olean-12-en-28-oic acid 28-O-beta-D-glucopyranosyl ester
11,12,11,12-tetradehydro-[11,18]bi[12,23-seco-24-nor-strychnidine]-10,10-dione|Sangucin|sungucine
3beta,6beta-dihydroxylup-20(29)-en-28-oic acid beta-glucopyranosyl ester
ilexasprellanoside C|[(3beta)-19,28-dihydroxy-28-oxours-12-en-3-yl]-beta-D-glucopyranosyluronic acid
(22R)-27-hydroxy-7alpha-methoxy-1-oxowitha-3,5,24-trienolide
2alpha-O-trans-p-coumaroyl-3beta,19alpha-dihydroxy-urs-12-en-28-oic acid
ilexasprellanoside F|[(3beta,19alpha)-19,28-dihydroxy-28-oxoolean-12-en-3-yl]-beta-D-glucopyranosyluronic acid
longispinogenin 3-O-beta-D-glucuronopyranoside|Longispinogenin 3-O-??-D-glucuronopyranoside
3beta-O-trans-caffeoyl-2alpha-hydroxyolean-12-en-28-oic acid
3-O-beta-D-Glucopyranoside-1,3-Dihydroxycycloart-24-en-28-oic acid
16??-Hydroxy-18??H-oleanolic acid-28-O-??-D-glucopyranoside
28-O-trans-caffeoyl-3beta,28-dihydroxy-20(29)-lupen-27-oic acid
(3beta,5alpha,11alpha,12beta,14beta)-12-acetoxy-3-[(2,6-dideoxy-4-O-methyl-beta-D-arabino-hexopyranosyl)oxy]-20-oxo-8,14-epoxypregnan-11-yl 2-methylbutanoate|3-O-olivomosyl-11-O-(2-methylbutanoyl)-12beta-O-acetyl-tenacigenin B|tenacigenoside B
30-(4-Hydroxycinnamoyl)-(3alpha,21beta)-3,21,24,30-Tetrahydroxy-14-serraten-16-one
3beta,23-dihydroxy-olean-12-en-28-oic acid 23-caffeate
3beta,19alpha-dihydroxyolean-12-en-28-oic acid 28-beta-D-glucopyranoside|siaresinolic acid 28-O-beta-D-glucopyranosyl ester
3beta,23-dihydroxy-olean-12-en-28-oic acid 3beta-caffeate
23(R),24(S),25(R),26(S)-16beta/23,23/26,24/25-triepoxy-6alpha,26-dihydroxy-9,9-cyclolanosta-3-O-beta-xyloside|bicusposide C
(24S)-ergostane-1beta,3beta,5alpha,6beta,25-pentaol 1,3,6,25-tetraacetate
2alpha,3beta,23-trihydroxy-30-norolean-12-en-28-oic acid beta-D-glucopyranosyl ester|2alpha,3beta,23-trihydroxy-30-norolean-12-en-28-oic acid monoglycoside|Mutangsaponin A
3beta-[(alpha-L-arabinopyranosyl)oxy]-11alpha,12alpha-epoxy-13beta,16alpha,23-trihydroxyoleanan-28-oic acid gamma-lactone
Momordicoside L
Momordicoside L is a cucurbitacin. CID 101743788 is a natural product found in Momordica charantia with data available.
3-O-cis-p-Coumaroyltormentic acid
POMOLICACIDBETA-D-GLUCOPYRANOSYLESTER
Pomolic acid 28-O-beta-D-glucopyranosyl ester is a natural product found in Sanguisorba officinalis, Ilex oblonga, and other organisms with data available.
Cimicifugoside H2
Cimicifugoside h 2 is a triterpenoid. Cimicifugoside H-2 is a natural product found in Actaea elata, Actaea cimicifuga, and other organisms with data available.
Echinocystic acid 28-O-β-D-glucoside
Echinocystic acid 28-O-β-D-glucoside is a metabolite of Echinocystic acid by microbial oxidation and glucosidation. Echinocystic acid 28-O-β-D-glucoside is a tissue factor pathway inhibitor, with an IC50 of 10.61 nM[1].
Siaresinolic acid 28-O-β-D-glucopyranosyl ester
Siaresinolic acid 28-O-beta-D-glucopyranosyl ester is a natural product found in Ilex oblonga with data available.
Momordicoside P
(2R,3R,4R,5S,6R)-2-[[(1R,4S,5S,8R,9R,12S,13S,16S,19R)-19-hydroxy-8-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol is a natural product found in Momordica charantia with data available.
W8WIS748XQ
25-O-Methylcimigenol-3-o-beta-D-xyloside is a natural product found in Actaea pachypoda with data available.
Olean-12-ene-23,28-dioic acid, 16-hydroxy-3-(beta-D-xylopyranosyloxy)-, (3beta,5xi,9xi,16alpha)
NCGC00347421-02_C35H54O10
C36H58O9_(1S,7S,9beta,23E)-9-Formyl-1,25-dihydroxy-10,14-dimethyl-4,9-cyclo-9,10-secocholesta-5,23-dien-7-yl beta-D-glucopyranoside
(3S,4S,6aR,6bS,8R,8aR,12aS,14bR)-8-hydroxy-4,6a,6b,11,11,14b-hexamethyl-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylic acid_major
(3S,4S,6aR,6bS,8R,8aR,12aS,14bR)-8-hydroxy-4,6a,6b,11,11,14b-hexamethyl-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylic acid_minor
Pandaroside B
Lucyoside O
Lucyoside Q
2a-Hydroxypyracrenic acid
1,4,7-Heptanetriol
Momordicin II
28-Glucosylpomolate
Soyasapogenol B 3-O-b-D-glucuronide
Magnesium ethylate
12-beta-acetoxy-3beta,15alpha,16alpha,24alpha-tetrahydroxy25,26,27-trinor-16,24-cyclo-cycloart-7-en-23-one-3-O-beta-D-xylopyranoside
1,4-bis(diethoxyphosphorylmethyl)-2,5-dioctoxybenzene
C32H60O8P2 (634.3763220000001)
2-Pyrrolidinyl-3-acetyl Desmorpholinylrocuronium Bromide
C34H55BrN2O4 (634.3344969999999)
2-(4-Hydroxy-1,3-thiazol-3-ium-3-yl)ethyl [2-(octadecylcarbamoyloxymethyl)oxolan-2-yl]methyl phosphate
Flexirubin
The parent member of the class of flexirubins obtained by formal condensation of the carboxy group of 17-(4-hydroxy-3-methylphenyl)heptadeca-2,4,6,8,10,12,14,16-octaenoic acid with one of the phenolic hydroxy groups of 2-dodecyl-5-methyl resorcinol.
caudatin-3-O-beta-cymaropyranoside
A steroid glycoside that is 3,8,12,14,17-pentahydroxypregn-5-en-20-one esterified at position 12 by (2E)-3,4-dimethylpent-2-enoic acid and glycosylated at the 3beta-hydroxy group by beta-cymaropyranose (the 3beta,12beta,14beta,17alpha stereoisomer). It is isolated from the roots of Cynanchum auriculatum and displays antineoplastic activity.
3beta,23-dihydroxyurs-12-en-28-oic acid 28-O-beta-D-glucopyranoside
A triterpenoid saponin that is 28-O-beta-D-glucopyranosyl derivative of 23-hydroxyursolic acid. It has been isolated from the leaves and twigs of Juglans sinensis.
3beta,22alpha-dihydroxyurs-12-en-28-oic acid 28-O-beta-D-glucopyranoside
A triterpenoid saponin that is urs-12-ene substituted by hydroxy groups at positions 3 and 22, an oxo group at position 28 and a beta-D-glucopyranosyloxy group at position 28. It has been isolated from the leaves and twigs of Juglans sinensis.
Card-20(22)-enolide, 3-[[2,6-dideoxy-4-O-(2,6-dideoxy-beta-D-ribo-hexopyranosyl)-beta-D-ribo-hexopyranosyl]oxy]-14-hydroxy-, (3beta,5beta)-
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
2-[[(2R)-3-acetyloxy-2-[(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C30H53NO11P+ (634.3356057999999)
2-[[(2R)-2-acetyloxy-3-[(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C30H53NO11P+ (634.3356057999999)
2-[[(2R)-3-acetyloxy-2-[(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C30H53NO11P+ (634.3356057999999)
2-[[(2R)-2-acetyloxy-3-[(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C30H53NO11P+ (634.3356057999999)
2-[[(2R)-3-acetyloxy-2-[(5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C30H53NO11P+ (634.3356057999999)
2-[[(2R)-2-acetyloxy-3-[(5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C30H53NO11P+ (634.3356057999999)
3-O-trans-p-coumaroyltormentic acid
A natural product found in Ficus mucuso.
withalongolide I
A withanolide saponin that consists of 3-hydroxy-22,26-epoxyergosta-5,24-diene substituted by additonal hydroxy groups at positions 19 and 27, oxo groups at positions 1 and 26 and a beta-D-glucopyranosyl residue at position 3 via a glycodic linkage. It has been isolated from Physalis longifolia.
(3S,7S,8S,9R,13R,14S,17R)-3-hydroxy-17-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-4,4,13,14-tetramethyl-7-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-9-carbaldehyde
Pilsicainide hydrochloride hydrate
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators
(1R,13R,14E,19S,21S)-14-ethylidene-10-[(1R,12S,13R,14E,17R,19S,21S)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,10-tetraen-17-yl]-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,10-tetraen-9-one
(1R,13S,14E,19S,21S)-14-ethylidene-10-[(1R,12S,13R,14E,17R,19S,21S)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,10-tetraen-17-yl]-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,11-tetraen-9-one
(1R,12S,13R,14E,19S,21S)-14-ethylidene-10-[(1R,12S,13R,14E,17R,19S,21S)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,10-tetraen-17-yl]-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,10-tetraen-9-one
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] undecanoate
[1-decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] decanoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate
[(4E,8E,12E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxytetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
[(E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
C32H59O10P (634.3845643999999)
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate
C32H59O10P (634.3845643999999)
[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate
C32H59O10P (634.3845643999999)
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate
C32H59O10P (634.3845643999999)
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate
C32H59O10P (634.3845643999999)
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
C32H59O10P (634.3845643999999)
[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate
C32H59O10P (634.3845643999999)
[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] (Z)-tridec-9-enoate
C32H59O10P (634.3845643999999)
[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
C32H59O10P (634.3845643999999)
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate
C32H59O10P (634.3845643999999)
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
C32H59O10P (634.3845643999999)
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate
C32H59O10P (634.3845643999999)
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate
C32H59O10P (634.3845643999999)
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
C32H59O10P (634.3845643999999)
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate
C32H59O10P (634.3845643999999)
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate
C32H59O10P (634.3845643999999)
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tridec-9-enoate
C32H59O10P (634.3845643999999)
[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
C32H59O10P (634.3845643999999)
[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate
[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (4E,7E)-hexadeca-4,7-dienoate
[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
[1-[(E)-dec-4-enoyl]oxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
[1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate
C32H59O10P (634.3845643999999)
[1-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
soyasapogenol B 3-O-beta-glucuronide
A triterpenoid saponin that is the 3-O-beta-glucuronide of soyasapogenol B.
(3b,20R,22R)-3,20,27-Trihydroxy-1-oxowitha-5,24-dienolide 3-glucoside
25-O-Methoxycimigenol 3-O-alpha-L-arabinopyranoside
A triterpene glycoside that consists of 25-O-methoxycimigenol attached to a alpha-L-arabinopyranosyl residue at position 3 via a glycosidic linkage. Isolated from the rhizomes of Cimicifuga racemosa, it exhibits cytotoxic activities.
9-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
1-{13-hydroxy-3-[5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-7,11-dioxo-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadecan-9-yl}ethyl acetate
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-6a,6b,9,12a-tetramethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
(1r,2r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-1-[(2s)-6-methyl-3-oxo-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl acetate
(2r,3r,4s,5r,6r)-2-{[(1s,2s,4s,5r,8r,9r,10s,13s,14r,17s,18s)-2-hydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-en-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
1-(2,7-dihydroxy-6-methylhept-5-en-2-yl)-3a,6,6,9b,11a-pentamethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one
(4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
11-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(4as,6as,6br,8ar,9r,10s,11r,12ar,12br,14br)-10,11-dihydroxy-9-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(2r,3r,4r,5s,6r)-2-{[(4s,5s,6s)-5-hydroxy-6-[(1r,4s,5s,8r,9r,12s,13s,16s)-16-hydroxy-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-8-yl]-2-methylhept-2-en-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
10-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-11-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
2-{[2,16-dihydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracos-4-en-9-yl]oxy}oxane-3,4,5-triol
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1,10-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
2-{[16-hydroxy-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5r,6r)-2-{[(1s,2s,4s,5r,8r,9r,10s,13s,14r,17s,18r,21s)-2,21-dihydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-en-10-yl]oxy}-6-methyloxane-3,4,5-triol
(4as,6as,6br,9r,10s,12ar,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(4ar,5r,6as,6br,8ar,10s,12ar,12br,14bs)-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(2s,3s,4s,5r,6r)-6-{[(3s,4s,4as,6ar,6bs,8ar,9r,12ar,14as,14br)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
(2s,3r,4s,5r)-2-{[(1s,2r,3s,4r,7r,9s,12r,14s,17r,18r,19r,21r,22s)-2-hydroxy-22-(2-methoxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}oxane-3,4,5-triol
4,10-dihydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-1-one
(2r,3r,4s,5s,6r)-2-{[(1s,2s,4s,5r,8r,9r,10s,13s,14r,17s,18r)-2-hydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-en-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
11-hydroxy-9-(hydroxymethyl)-10-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
2-{[5-(3-hydroxy-3-methylpent-4-en-1-yl)-1-(hydroxymethyl)-1,4a,6-trimethyl-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]-hexahydro-2h-naphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4ar,6as,6br,8ar,10s,12ar,12br,14bs)-1,10-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
3-(acetyloxy)-2-(hydroxymethyl)-5-[(2-methylpropanoyl)oxy]-6-(2,3,4-trihydroxybutoxy)oxan-4-yl hexadecanoate
(2s,4ar,6as,6br,8ar,9s,10s,12ar,12br,14bs)-9-(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2,4a-dicarboxylic acid
16beta-hydroxy-18beta-h-oleanolic acid-28-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN001827","Ingredient_name": "16beta-hydroxy-18beta-h-oleanolic acid-28-o-beta-d-glucopyranoside","Alias": "16\u03b2-hydroxy-18\u03b2h-oleanolicacid-28-o-\u03b2-d-glucopyranoside","Ingredient_formula": "C36H58O9","Ingredient_Smile": "CC1(CCC2(C(C1)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)C)O)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31244;10550","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
23-trans-p-coumaroyloxy-2α,3β-dihydroxy-olean-12-en-28-oicacid
{"Ingredient_id": "HBIN004178","Ingredient_name": "23-trans-p-coumaroyloxy-2\u03b1,3\u03b2-dihydroxy-olean-12-en-28-oicacid","Alias": "NA","Ingredient_formula": "C39H54O7","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)COC(=O)C=CC6=CC=C(C=C6)O)O)O)C)C)C2C1)C)C(=O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4180","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
25-o-methoxycimigenol 3-o-α-l-arabinopyra-noside
{"Ingredient_id": "HBIN004709","Ingredient_name": "25-o-methoxycimigenol 3-o-\u03b1-l-arabinopyra-noside","Alias": "NA","Ingredient_formula": "C36H58O9","Ingredient_Smile": "CC1CC2C(OC3(C1C4(CCC56CC57CCC(C(C7CCC6C4(C3O)C)(C)C)OC8C(C(C(CO8)O)O)O)C)O2)C(C)(C)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13874","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
25-o-methylcimigenoside
{"Ingredient_id": "HBIN004711","Ingredient_name": "25-o-methylcimigenoside","Alias": "NA","Ingredient_formula": "C36H58O9","Ingredient_Smile": "CC1CC2C(OC3(C1C4(CCC56CC57CCC(C(C7CCC6C4(C3O)C)(C)C)OC8C(C(C(CO8)O)O)O)C)O2)C(C)(C)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14237","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
28-O-β-D-glucopyranosyl pomolic acid
{"Ingredient_id": "HBIN005078","Ingredient_name": "28-O-\u03b2-D-glucopyranosyl pomolic acid","Alias": "NA","Ingredient_formula": "C36H58O9","Ingredient_Smile": "CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1(C)O)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35958","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,29-o-dibenzoyloxykarounidiol
{"Ingredient_id": "HBIN007034","Ingredient_name": "3,29-o-dibenzoyloxykarounidiol","Alias": "NA","Ingredient_formula": "C43H54O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5385","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β,19α-dihydroxyurs-12-en-28-oicacid 28-β-d-glucopyranosyl ester
{"Ingredient_id": "HBIN008045","Ingredient_name": "3\u03b2,19\u03b1-dihydroxyurs-12-en-28-oicacid 28-\u03b2-d-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C36H58O9","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1O)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15138","TCMID_id": "6175","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-cis-p-coumaroyloxy-2α,23-dihydroxyolean-12-en-28-oicacid
{"Ingredient_id": "HBIN008195","Ingredient_name": "3\u03b2-cis-p-coumaroyloxy-2\u03b1,23-dihydroxyolean-12-en-28-oicacid","Alias": "NA","Ingredient_formula": "C39H54O7","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)OC(=O)C=CC6=CC=C(C=C6)O)O)C)C)C2C1)C)C(=O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4179","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3 e)-coumaroylarjunolicacid
{"Ingredient_id": "HBIN008458","Ingredient_name": "(3 e)-coumaroylarjunolicacid","Alias": "NA","Ingredient_formula": "C39H54O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4151","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-o-beta-d-xylopyranosyl-esculentic acid
{"Ingredient_id": "HBIN009265","Ingredient_name": "3-o-beta-d-xylopyranosyl-esculentic acid","Alias": "3-o-\u03b2-d-xylopyranosyl-esculenticacid","Ingredient_formula": "C35H54O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32240;22806","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-O-cis-p-Coumaroyl tormentic acid
{"Ingredient_id": "HBIN009296","Ingredient_name": "3-O-cis-p-Coumaroyl tormentic acid","Alias": "NA","Ingredient_formula": "C39H54O7","Ingredient_Smile": "CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)OC(=O)C=CC6=CC=C(C=C6)O)O)C)C)C2C1(C)O)C)C(=O)O","Ingredient_weight": "634.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37795","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "133562427","DrugBank_id": "NA"}
(1r,3as,3bs,4r,7s,9ar,9br,11ar)-7-hydroxy-1-[(2r,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-3a,6,6,11a-tetramethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde
(2s,3s,4s,5r,6r)-6-{[(3ar,3br,5as,7s,9as,9bs,11as)-1-[(2r,5r)-5-ethyl-6-methyl-4-oxoheptan-2-yl]-2-hydroxy-9a,11a-dimethyl-3-oxo-3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
(2r)-2-[(1r,3ar,4r,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoic acid
2-{4',5,6',12',17',17'-hexamethyl-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane]-4,15'-dioloxy}oxane-3,4,5-triol
(1s)-1-[(1r,3r,4s,5r,9r,13s,14r)-13-hydroxy-3-[(2r,5s)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-7,11-dioxo-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadecan-9-yl]ethyl acetate
(1r,2s,4as,6as,6br,8ar,10r,11r,12ar,12br,14br)-10-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-11-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
(2r,3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl (4as,6as,6br,8r,8ar,9r,10r,12ar,12br,14bs)-8,10-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-11-oxo-3,4,5,6,7,8,8a,10,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylate
10-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-11-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(4as,6as,6br,8as,9r,10s,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
11-hydroxy-9-(hydroxymethyl)-10-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
(4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-10-{[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(2s)-5-[(2s)-n,3-dihydroxy-2-{[(2s)-1-hydroxy-5-(n-hydroxyacetamido)-2-(methylamino)pentylidene]amino}propanamido]-n-[(1s)-2-hydroxy-1-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl]-2-(methylamino)pentanimidic acid
3,4,5-trihydroxy-6-{[8-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}oxane-2-carboxylic acid
(1r,3as,3bs,4s,7s,9ar,9br,11ar)-4-hydroxy-1-[(2r,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-3a,6,6,11a-tetramethyl-7-{[(2r,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde
(2r)-2-[(1r,3ar,4s,5as,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoic acid
(2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,8s,8as,12as,14ar,14br)-8-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
14-ethylidene-10-{14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-17-yl}-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-9-one
(1s,2r,4as,6as,6br,8ar,9s,10r,11r,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
(1s,3as,3bs,7s,9ar,9br,11ar)-1-[(2s,5z)-2,7-dihydroxy-6-methylhept-5-en-2-yl]-3a,6,6,9b,11a-pentamethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one
5-(acetyloxy)-5-{3'-[(acetyloxy)methyl]-2-hydroxy-9a,11a-dimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2-hydroxy-2,3,4-trimethylpentyl acetate
(1s,2r,4as,6as,6br,8ar,9s,10s,12ar,12bs,14bs)-10-hydroxy-9-({[(2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6b,9,12a-pentamethyl-1,2,3,4,5,6,6a,7,8,8a,10,11,12,12b,13,14b-hexadecahydropicene-4a-carboxylic acid
9-({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
10-hydroxy-15-(5-hydroxy-6-methyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-5-en-4-one
(1s,3r,8r,11s,12s,14s,15r,16r)-14-hydroxy-15-[(2s)-5-isopropyl-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-one
(2s,3r,4s,5s,6r)-2-{[(1s,3s,7r,9r,12s,13r,16s,17s,18r,19s,20s,21s,22s)-21-ethyl-17-hydroxy-12,16,18,22-tetramethyl-24,25,26-trioxaheptacyclo[18.4.1.1¹⁹,²².0¹,¹⁷.0³,¹⁶.0⁴,¹³.0⁷,¹²]hexacos-4-en-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(1r,2s,4as,5r,6r,8ar)-5-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-1-(hydroxymethyl)-1,4a,6-trimethyl-6-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-hexahydro-2h-naphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
4,7-dihydroxy-3a,6,6,11a-tetramethyl-1-(6-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hept-5-en-2-yl)-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde
(2r)-2-[(1r,3ar,4r,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoic acid
(1r,3as,3bs,4s,7s,9ar,9br,11ar)-4-hydroxy-1-[(2r,4r)-4-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,11a-tetramethyl-7-{[(2r,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde
(1r,3as,5as,5br,7ar,9s,11ar,11br,13ar,13br)-3a-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-9-hydroxy-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-5a-carboxylic acid
(2r,3r,4s,5s,6r)-3-(acetyloxy)-2-(hydroxymethyl)-5-[(2-methylpropanoyl)oxy]-6-[(2r,3s)-2,3,4-trihydroxybutoxy]oxan-4-yl hexadecanoate
(4as,6as,6br,8ar,9s,10s,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(3s,6s,9r,12s,15s)-3,12-dibenzyl-5,8,11,14-tetrahydroxy-6,9,15-tris(2-methylpropyl)-1-oxa-4,7,10,13-tetraazacyclopentadeca-4,7,10,13-tetraen-2-one
(1r,2s,3s,4s)-1-[(1r,2s,3's,3as,3br,5as,9as,9bs,11as)-3'-[(acetyloxy)methyl]-2-hydroxy-9a,11a-dimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-5-(acetyloxy)-4-hydroxy-2,3,4-trimethylpentyl acetate
(2r,4ar,6as,6br,8ar,10s,12ar,12br,14br)-2-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-10-hydroxy-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(1s,2r,4as,6as,6br,8ar,9s,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-({[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
(1r,12s,13r,14e,17r,19s,21s)-14-ethylidene-17-[(1r,12s,13r,14e,19s,21s)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-10-yl]-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-9-one
9-(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2,4a-dicarboxylic acid
(1s,3ar,3br,4r,7r,9bs,11as)-7-hydroxy-1-[(2s,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-3a,6,6,11a-tetramethyl-4-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde
2-{[2-hydroxy-22-(2-methoxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}oxane-3,4,5-triol
9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
3a-({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-9-hydroxy-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-5a-carboxylic acid
(6r)-6-[(1r)-1-[(1s,3ar,3br,7r,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-9-oxo-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one
2-{[2,21-dihydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-en-10-yl]oxy}-6-methyloxane-3,4,5-triol
(1r,2s,3as,3br,5ar,7s,9as,9bs,11ar)-7-{[(2r,3r,4r,5s,6s)-3-(acetyloxy)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate
(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-(acetyloxy)-15-[(2r,3r,5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate
6-(hydroxymethyl)-3',3a,6,9a,11a-pentamethyl-5'-propanoyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5,5a,7,8,9,10,11-octahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-3-one
(4as,6ar,6br,8ar,9r,10s,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(2r,3r,4s,5s,6r)-2-{[(1s,2s,4s,5r,8r,9r,10s,13s,17s,18r)-2-hydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-en-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,2r,4as,6as,6br,8ar,9s,10s,12ar,12bs,14bs)-10-hydroxy-9-({[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6b,9,12a-pentamethyl-1,2,3,4,5,6,6a,7,8,8a,10,11,12,12b,13,14b-hexadecahydropicene-4a-carboxylic acid
(3r,3ar,4r,5ar,5br,7ar,9r,10r,11as,13as,13bs)-4,10-dihydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-1-one
(1r,12s,13r,14e,19s,21s)-14-ethylidene-10-[(1r,12r,13r,14e,17r,19s,21s)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-17-yl]-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-9-one
(4as,6ar,6br,8ar,12ar,12br,14bs)-6a-({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-10-hydroxy-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(2r,3r,4s,5s,6r)-2-{[(1s,2r,5r,7s,10r,11r,14r,15s,16s,17r,20r)-16-hydroxy-2,6,6,10,16-pentamethyl-17-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
10-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(1s,2r,4as,6as,6br,9s,10r,11r,12ar)-10,11-dihydroxy-9-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
(1s,3ar,3bs,7s,9ar,9br,11r,11as)-1-acetyl-1,3a,3b-trihydroxy-7-{[(2r,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl (2e)-3,4-dimethylpent-2-enoate
3-(acetyloxy)-6-{2-[7-(acetyloxy)-2,2,5a,7-tetramethyl-3-oxo-hexahydro-1-benzoxepin-6-yl]ethyl}-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate
(4as,6as,6br,8ar,9r,10s,11r,12ar,12br,14br)-10,11-dihydroxy-9-({[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(3s,5as,6s,7s,9as)-6-{2-[(5as,6s,7r,9as)-7-(acetyloxy)-2,2,5a,7-tetramethyl-3-oxo-hexahydro-1-benzoxepin-6-yl]ethyl}-3-(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate
(1s,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-10-{[(2z)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-11-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
(1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,11-dihydroxy-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(4as,6as,6br,8ar,9r,10s,12ar,12br,14br)-9-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(2r,3r,4s,5s,6r)-2-{[(1s,2s,4s,5r,8r,9r,10s,13s,14r,17s,18r,19s,20r)-2-hydroxy-9-(hydroxymethyl)-4,5,9,13,19,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-en-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-10-hydroxy-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(2s)-6-amino-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-methylbutylidene]amino}hexanoic acid
C32H54N6O7 (634.4053773999999)
methyl (1s,2s,3s,4r,5r,8r,13s,14s,17s,18r,20r,21r,22r,25s)-3,21-bis(acetyloxy)-2,13,20,25-tetrahydroxy-5,8,22-trimethyl-11-methylidene-24-oxahexacyclo[15.5.3.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]pentacosane-14-carboxylate
(2r,3r,4s,5s,6r)-2-{[(2r,4s,5r,13s,18s)-2-hydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-en-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,2r,4as,6as,6br,8ar,9r,10s,11r,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
(1r,13r,14e,19s,21s)-14-ethylidene-10-[(1r,12s,13r,14e,17r,19s,21s)-14-ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-17-yl]-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10-tetraen-9-one
6-amino-2-{[2-({2-[(2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-4-methylpentylidene)amino]-1-hydroxy-4-methylpentylidene}amino)-1-hydroxy-3-methylbutylidene]amino}hexanoic acid
C32H54N6O7 (634.4053773999999)